文献速递免疫规划

更新的甲型H3N2流感疫苗对儿童既往 encountered 抗原产生有限抗体应答

An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children.
PubMed 文献 · Vaccine · 2017-12-15

研究对124名5-17岁儿童接种含抗原更新甲型H3N2株的2015-2016灭活流感疫苗,用血凝抑制试验检测接种前后血清。疫苗株几何平均滴度显著升高(P<.0001),针对疫苗株平均fold increase为3.29,针对历史株为1.22-1.46。结论:抗原新型甲型H3N2疫苗 modestly boosted 儿童对历史流感株的抗体应答。

要点

  • 接种含抗原更新甲型H3N2株疫苗后,各检测抗原几何平均滴度均显著升高(P<.0001)。
  • 针对疫苗株平均fold increase为3.29,针对历史株为1.22-1.46。
  • 对疫苗株的应答与针对历史株接种后滴度升高相关。

核心结论

  • 含抗原新型甲型H3N2株的疫苗 modestly boosted 儿童对历史流感株的抗体应答。

研究设计与样本

  • 对124名5-17岁儿童接种2015-2016灭活流感疫苗(含抗原更新甲型H3N2株)前后的血清进行血凝抑制试验。
  • 采用线性回归评估与接种后针对历史株滴度相关的因素,并校正基线滴度。

主要发现

  • 针对每个检测抗原的几何平均滴度在接种后均显著升高(P<.0001)。
  • 针对疫苗株的平均fold increase为3.29,针对历史株为1.22-1.46。
  • 对疫苗株的应答与接种后针对历史株滴度升高相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Influenza vaccination may provide a "back-boost" to antibodies against previously encountered strains. If the back-boost effect is common, this could allow more aggressive vaccine updates, as emerging variants would be expected to both elicit de-novo responses and boost pre-existing responses against recently circulating strains. Here we used the emergence of an antigenically novel A(H3N2) strain to determine whether an antigenically updated vaccine boosted antibodies against historical strains. METHODS: We performed hemagglutination-inhibition (HI) assays on pre- and post-vaccination sera from 124 children 5-17 years old who received 2015-2016 inactivated influenza vaccine, containing an antigenically updated A(H3N2) strain. We evaluated the mean fold increase in HI titer against both the 2015-2016 vaccine strain and representative strains from two prior antigenic clusters. Factors associated with post-vaccination titers against historical strains were evaluated using linear regression, adjusting for baseline titer. RESULTS: Geometric mean titers against each antigen examined increased significantly after vaccination (P < .0001). Mean fold increase was 3.29 against the vaccine strain and 1.22-1.46 against historical strains. Response to vaccine strain was associated with increased post-vaccination titers against historical strains. CONCLUSIONS: A vaccine containing an antigenically novel A(H3N2) strain modestly boosted antibody responses against historical influenza strains in children.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Florek KR, Campos LM, Braun KM, et al. An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children. Vaccine. 2017. PMID: 29249543. doi:10.1016/j.vaccine.2017.12.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。